Ampio Pharmaceuticals
(OTCPK:AMPE)
$0.62
0[0.00%]
At close: Apr 12

Ampio Pharmaceuticals Stock (OTC:AMPE), Earnings Estimates, EPS, and Revenue

Ampio Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Mar 27
EPS
$-2.480
Quarterly Revenue
$0K
Annual Revenue
(as of Dec 31)

Analyze the earnings history of Ampio Pharmaceuticals using advanced sorting and filters.

Date
time
ticker
Quarter
Prior EPS
Est EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert
05/06/2024PMAMPEQ1-$5.20$0.00Get Alert
03/27/2024PMAMPEQ4-$3.60-$2.48$0.00$0.00Get Alert
11/14/2023PMAMPEQ3-$10.00-$1.53$0.00$0.00Get Alert
08/08/2023PMAMPEQ2-$6.00-$1.80$0.00$0.00Get Alert
05/08/2023PMAMPEQ1-$9.00-$5.20$0.00$0.00Get Alert
03/27/2023PMAMPEQ4-$12.00-$3.60$0.00$0.00Get Alert
11/14/2022PMAMPEQ3-$6.00-$6.00-$10.00-66.67%$0.00$0.00Get Alert
08/09/2022PMAMPEQ2-$6.00-$6.00-$6.000.00%$0.00$0.00Get Alert
05/16/2022PMAMPEQ1-$6.00-$6.00-$9.00-50.00%$0.00$0.00Get Alert
03/29/2022PMAMPEQ4-$6.00-$6.00-$12.00-100.00%$0.00$0.00Get Alert
11/10/2021PMAMPEQ3-$6.00-$6.00-$6.000.00%$0.00$0.00Get Alert
08/04/2021PMAMPEQ2-$6.00-$6.00-$6.000.00%$0.00$0.00Get Alert
05/05/2021PMAMPEQ1-$6.00-$6.000.00%$0.00Get Alert
03/03/2021PMAMPEQ4-$6.00$0.00Get Alert
11/05/2020PMAMPEQ3-$6.00$0.00Get Alert
07/31/2020AMAMPEQ2-$6.00$0.00Get Alert

FAQ

Q

When is Ampio Pharmaceuticals (OTCPK:AMPE) reporting earnings?

A

Ampio Pharmaceuticals (AMPE) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on March 27, 2024 for Q4.

Q

What were the latest earnings per share (EPS) for Ampio Pharmaceuticals (OTCPK:AMPE)?

A

The Actual EPS was $-2.48, which missed the estimate of $0.00.

Q

What were Ampio Pharmaceuticals’s (OTCPK:AMPE) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.